The good news is that we're getting the first hints of positive...

The good news is that we're getting the first hints of positive results from direct measurements of tumours of the stabilisation of late stage cancers in a dog after a short period of treatment in the Cambridge Uni  (UK) trials. So the second phase of trials is off to a great start and shows this is no wannabe long shot, but something special and ready to go.

When the first initial progress results on these dog trials become available (end of this year, early next ?) this would be a great opportunity to kick off the media campaign in the most widely read share market and business news media and blogs. But these stories must reflect that PAA's program is now into it's second phase and has 4 years of work behind it. If you look at this (lonely) headline for instance  from the Ausgust 16 at Proactive: "PharmAust to begin Cancer Trials" you get the impression that the program is only just starting and is an intial kite flying or long shot exercise with a very high probability of failure and a very long way to go. It should have read "PharmAust to begin second phase of cancer tests" to get across the message that much work has already been done, the results were positive, and progress is well advanced and being made. Then we need regular updates in the media of the progress being made. It's crucial to build and maintain interest momentum before the NASDAQ listing to ensure for the best possible result. If PAA are going to have chance of being taken notice of in a very cluttered and noisy public media space, they must think carefully of things as simple and obvious as even the wording of headlines. (You nailed it NZ)